
If you have been looking into regenerative skin treatments, you have probably come across exosomes treatment and polynucleotides treatment. Both are often described as ways to improve skin quality, stimulate repair and support a more refreshed appearance.
But they are not the same thing.
The names can make them sound interchangeable, particularly when both are marketed as alternatives to traditional injectables. In reality, they differ in what they contain, how they are thought to work, how they are delivered and how much clinical evidence is available.
So, what is the actual difference between exosomes and polynucleotides, and which one might be more appropriate for your skin?
What Are Exosomes?
Exosomes are tiny extracellular vesicles released by cells. They are involved in communication between cells and can carry biological signals, including proteins, lipids and nucleic acids. In dermatology, researchers are interested in their potential role in processes such as skin repair, inflammation and tissue regeneration.
In aesthetic medicine, exosomes treatment generally refers to the use of exosome-containing preparations to support skin rejuvenation. Depending on the product and protocol, they may be applied topically or used alongside procedures such as microneedling or laser treatment.
The important point is that exosomes are not a single standardised treatment. Their source, preparation, concentration and method of delivery can vary considerably. This matters because the evidence for one preparation cannot automatically be applied to another.
What Are Polynucleotides?
Polynucleotides are chains of nucleotides, the building blocks of DNA. In aesthetic medicine, they are used in injectable treatments designed to support skin quality and regeneration.
Rather than adding volume in the way a dermal filler does, polynucleotide treatment is intended to work through biological processes within the skin. Research has explored their potential to improve hydration, elasticity, texture and the appearance of fine lines.
Polynucleotides are often discussed alongside PDRN, or polydeoxyribonucleotide. The terms are related, but they are not necessarily interchangeable. The exact product, formulation and treatment protocol matter.
And, as with any aesthetic treatment, the fact that a product is described as “regenerative” does not mean it is suitable for every skin concern. Our guide to whether polynucleotides work looks at the evidence in more detail.
Exosomes vs Polynucleotides: What Is the Difference?
The simplest way to understand the difference is to look at what the treatment contains and what it is intended to do.
| Exosomes treatment | Polynucleotides treatment | |
| What is it? | A preparation containing extracellular vesicles that carry biological signals between cells. | A treatment using chains of nucleotides, the building blocks of DNA. |
| How does it work? | Exosomes are being studied for their role in cell communication and processes involved in repair and regeneration. | Polynucleotides are thought to support skin repair and regeneration through biological pathways. |
| Main area of interest | Skin rejuvenation, repair and overall skin quality. | Skin quality, hydration, elasticity and the appearance of fine lines. |
| How is it delivered? | Depending on the product, it may be applied topically or used alongside procedures such as microneedling or laser. | Commonly delivered through injections into the skin. |
| What does it aim to improve? | The overall condition and appearance of the skin. | Skin quality, particularly where hydration, texture and resilience are concerns. |
| What should you expect? | Results depend on the preparation and treatment protocol. | Results are generally gradual and depend on the product, treatment plan and individual. |
| Evidence | Promising, but clinical research remains limited and preparations vary. | Promising research, although studies are still limited and treatment protocols are not yet fully standardised. |
The table is a useful starting point, but it is important not to treat these treatments as directly interchangeable. The evidence for exosomes is still developing, while research into polynucleotides has also identified limitations in study quality and consistency.
What Do Exosomes Treatment and Polynucleotides Treatment Have in Common?
Despite the differences, there are some similarities.
Both treatments are generally discussed in the context of skin quality rather than adding volume. They are not designed to replace dermal fillers, and neither is intended to relax facial muscles in the way anti-wrinkle injections do.
They are also associated with gradual changes rather than an immediate change in facial structure. The aim is usually to improve the condition of the skin over time, rather than simply changing its shape.
But this does not mean that both treatments will produce the same result.
The right choice depends on what you are trying to improve and what the treatment can realistically address.
What Is Exosomes Treatment Used For?
Exosomes treatment is being explored for several dermatological and aesthetic concerns, including skin rejuvenation, pigmentation, scarring and hair-related conditions. However, the evidence is still developing, and the results reported in studies cannot automatically be applied to every product or treatment protocol.
In aesthetic practice, exosome-containing preparations may be used as part of a broader skin-rejuvenation approach, sometimes alongside procedures such as microneedling or laser treatment.
The appeal is understandable. Exosomes are involved in cell communication, and researchers are interested in whether this can be used to support skin repair and renewal.
But it is worth being careful about the language used around them.
Exosomes are not a guaranteed way to regenerate your skin, and they are not a substitute for every other treatment. The preparation, delivery method and clinical evidence all matter.
What Is Polynucleotides Treatment Used For?
Polynucleotides treatment is generally used to improve skin quality rather than add volume.
Research has explored its use for concerns such as:
- Fine lines
- Uneven skin texture
- Reduced skin elasticity
- Dehydrated or less resilient skin
- Overall skin quality
A 2025 systematic review found promising results for wrinkle reduction, skin texture and elasticity, but also noted that the available studies were limited in quality and that there is not yet a clear consensus on the best treatment protocols.
This is important because polynucleotides are sometimes marketed as though they can do everything.
They cannot.
If your main concern is significant volume loss, for example, a treatment designed to improve skin quality may not give you the same result as a dermal filler.
Which Is Better: Exosomes or Polynucleotides?
There is no straightforward answer.
It depends on what your skin needs, what you are hoping to improve and which treatment is appropriate for you.
If your main concern is overall skin quality, both may be options worth discussing. But that does not mean they are equally suitable for every person or every area of the face.
For example, if you are concerned about fine lines, dehydration or changes in skin texture, a treatment aimed at improving skin quality may be appropriate. If you are concerned about volume loss, the approach may be different.
The important thing is not to choose a treatment simply because it is the latest one being discussed online.
Exosomes vs Polynucleotides: Which Has Better Evidence?
This is where the comparison becomes more complicated.
Both treatments have promising research behind them, but neither should be described as a fully established solution for every aesthetic concern.
For exosomes, a 2026 scoping review identified 17 human studies, but noted that the evidence was limited by small sample sizes, short follow-up periods and differences in how the treatments were prepared and delivered.
For polynucleotides, a 2025 systematic review found promising results in several studies, but also noted that the available evidence was of low to moderate quality and that there was limited consensus on optimal treatment protocols.
So, while both treatments are interesting, it is too early to say that one is universally better than the other.
The evidence matters, but so does the individual treatment plan.
Are Exosomes and Polynucleotides Safe?
As with any aesthetic treatment, safety depends on the product, the way it is used and the person receiving it.
Exosome preparations vary considerably, and the clinical evidence does not yet establish the safety and effectiveness of every preparation or delivery method. Reported adverse events in the literature have included allergic reactions and other complications, particularly in the context of injection.
Polynucleotide studies have generally reported mild and temporary side effects, but the available evidence is still limited and treatment protocols vary.
This is why it is important to understand what product is being used, how it is being delivered and whether it is appropriate for your skin.
A consultation should not simply be about choosing between two trendy treatments. It should be about understanding what is actually being recommended and why.
What About Results and Downtime?
Both treatments are generally associated with gradual changes rather than an immediate transformation.
The exact timeline depends on the product, the treatment area, the protocol and your individual response.
With injectable treatments, you may experience temporary redness, swelling or bruising. With topical or post-procedure exosome applications, downtime may depend more on the procedure they are used alongside.
It is also important to remember that a treatment that improves skin quality is not necessarily going to give you an immediate change in facial shape or volume.
If that is what you are looking for, you may need a different approach.
Can You Have Exosomes and Polynucleotides Together?
In some treatment plans, different regenerative approaches may be considered together or used at different stages.
However, there is no reason to assume that combining treatments will automatically produce a better result.
The decision should be based on what your skin needs, what each treatment is intended to do and whether there is a clear reason to use them together.
It is also important to remember that more treatment does not automatically mean better treatment.
What Should You Consider Before Choosing a Treatment?
Before choosing between exosomes and polynucleotides, it is worth asking a few simple questions:
- What is the main concern I want to improve?
- Is the treatment intended to improve skin quality or add volume?
- What product is being used?
- How is it being delivered?
- What evidence supports the treatment?
- What results are realistic?
- What are the possible side effects?
- Is the treatment appropriate for my skin?
These questions are more useful than simply asking which treatment is the most popular.
Book a Consultation at Perfect Skin Studio
If you are considering exosomes treatment or polynucleotides treatment, the most useful first step is to understand what your skin actually needs.
At Perfect Skin Studio, our doctors take a personalised approach to skin concerns. We assess your skin, discuss your goals and explain which treatment options may be appropriate for you.
The aim is not to recommend the newest treatment simply because it is trending. It is to understand what is causing your concern and whether a particular treatment is likely to help.
Perfect Skin Studio is based at 121 Harley Street, London. Our team includes experienced doctors specialising in surgical and non-surgical facial rejuvenation.
To discuss your skin concerns and find out whether exosomes treatment or polynucleotides treatment may be suitable for you, contact Perfect Skin Studio to arrange a consultation.
Frequently asked questions
Still unsure? Our team is glad to talk you through anything before you book.
- Exosomes are extracellular vesicles involved in cell communication, while polynucleotides are chains of nucleotides used in treatments intended to support skin repair and regeneration. Both are being explored for skin rejuvenation, but they are not the same treatment.
- No. They differ in what they contain, how they are thought to work and how they are delivered. The exact product and treatment protocol also matter.
- There is no universal answer. Both have promising research behind them, but the evidence is still developing. The right choice depends on your skin concerns, the product being used and what the treatment is intended to achieve.
- Exosomes treatment is generally intended to improve skin quality rather than add volume. If your main concern is volume loss, a different treatment may be more appropriate.
- Not necessarily. Polynucleotides are generally used to improve skin quality, while dermal fillers are designed to restore volume. They address different concerns.
- Results depend on the preparation, delivery method and treatment protocol. Changes are generally gradual, and there is no single timeline that applies to every exosome treatment.
- Results are generally gradual and depend on the product, treatment plan and individual response. A consultation can help you understand what may be realistic for your skin.
- Both treatments have reported benefits, but safety depends on the product, the way it is used and the person receiving it. The evidence is still developing, particularly for exosome preparations, so it is important to understand the treatment being recommended.
- In some cases, different treatments may be considered together or used at different stages. However, this should be based on your skin concerns and a clear treatment plan rather than assuming that combining treatments will always produce better results.
- Both may be considered for skin-quality concerns, but the right choice depends on what is causing the dullness. Dehydration, pigmentation, texture changes and ageing may require different approaches. A professional assessment can help determine what is most appropriate.






